Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies.

CONCLUSION: RTX could be an effective and relatively safe therapeutic option in patients with refractory IIM. PMID: 32989931 [PubMed - in process]
Source: Journal of Korean Medical Science - Category: Biomedical Science Tags: J Korean Med Sci Source Type: research